# FDA Inspection 1017391 - Dr. Rubin H. Saavedra - June 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/dr-rubin-h-saavedra/82df6f88-1d1d-48fe-99f3-082c9c845562
Source feed: FDA_Inspections

> FDA Inspection 1017391 for Dr. Rubin H. Saavedra on June 16, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017391
- Company Name: Dr. Rubin H. Saavedra
- Inspection Date: 2017-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 727733 - 2011-05-19](https://www.keypedia.com/records/fda_inspections/dr-rubin-h-saavedra/eebc7782-3587-4e49-a7aa-de84d2091672)
- [FDA Inspection 577820 - 2009-03-25](https://www.keypedia.com/records/fda_inspections/dr-rubin-h-saavedra/7e95a411-c315-4763-be8f-d8ecc56b5e33)

Company: https://www.keypedia.com/companies/dr-rubin-h-saavedra/f12ce492-520b-49c5-8434-40e4eed66652

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c